14.88

2.27% 0.3309

Adma Biologics Inc (ADMA)

Overview News Price History Option Chain Financials Discussions Forecast

Adma Biologics Inc stock is traded at $14.88, with a volume of 541.37K. It is up +2.27% in the last 24 hours and down -7.64% over the past month. ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.

Previous Close:

$14.55

Open:

$14.55

24h Volume:

541.37K

Relative Volume:

0.17

Market Cap:

$3.55B

Revenue:

$474.17M

Net Income/Loss:

$208.93M

P/E Ratio:

17.52

EPS:

0.8493

Net Cash Flow:

$65.61M

1W Performance:

+6.36%

1M Performance:

-7.64%

6M Performance:

-28.84%

1Y Performance:

-9.10%

1-Day Range:

$14.44

$14.94

1-Week Range:

$13.82

$14.94

52-Week Range:

$13.82

$25.67

Adma Biologics Inc Stock (ADMA) Company Profile

Name

Adma Biologics Inc

Sector

Healthcare (1146)

Industry

Biotechnology (639)

Phone

(201) 478-5552

Address

C/O ADMA BIOLOGICS, INC., RAMSEY

Employee

685

Twitter

@AdmaBiologics

Next Earnings Date

2025-03-03

Latest SEC Filings

ADMA's Discussions on Twitter

Compare ADMA with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
ADMA Adma Biologics Inc	14.89	3.47B	474.17M	208.93M	65.61M	0.8493
VRTX Vertex Pharmaceuticals Inc	409.57	104.55B	11.39B	3.64B	3.50B	13.99
ALNY Alnylam Pharmaceuticals Inc	460.83	60.36B	2.46B	-319.09M	-52.09M	-2.4669
REGN Regeneron Pharmaceuticals Inc	560.78	59.84B	14.21B	4.46B	3.56B	39.69
ARGX Argen X Se Adr	799.22	49.07B	3.06B	1.28B	447.35M	19.67
ONC Beone Medicines Ltd Adr	317.60	35.16B	4.56B	-176.77M	225.30M	-1.7177

Adma Biologics Inc Stock (ADMA) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jul-19-23	Resumed	Raymond James	Strong Buy
Oct-13-22	Initiated	Mizuho	Buy
Nov-11-21	Upgrade	Raymond James	Outperform → Strong Buy
Nov-09-21	Initiated	Cantor Fitzgerald	Overweight
Jun-04-19	Initiated	Jefferies	Buy
Apr-15-19	Reiterated	H.C. Wainwright	Buy
Feb-07-19	Resumed	H.C. Wainwright	Buy
Dec-11-17	Reiterated	Maxim Group	Buy
Nov-14-17	Upgrade	Raymond James	Mkt Perform → Outperform
Jan-23-17	Upgrade	Maxim Group	Hold → Buy
Aug-01-16	Downgrade	Maxim Group	Buy → Hold
Jul-25-16	Reiterated	Maxim Group	Buy
May-13-15	Reiterated	Maxim Group	Buy
Dec-08-14	Initiated	Oppenheimer	Outperform
Dec-01-14	Reiterated	Maxim Group	Buy

View All

Adma Biologics Inc Stock (ADMA) Latest News

07:11 AM

Sentiment analysis tools applied to ADMA Biologics Inc.Weekly Trading Summary & Advanced Swing Trade Entry Alerts - newser.com

07:11 AM

06:25 AM

Will ADMA Biologics Inc. rebound enough to break evenRate Cut & Reliable Breakout Forecasts - newser.com

06:25 AM

03:22 AM

Can ADMA Biologics Inc. stock attract ESG capital inflows2025 Short Interest & Community Verified Trade Signals - newser.com

03:22 AM

03:21 AM

What momentum shifts mean for ADMA Biologics Inc.Portfolio Return Report & AI Powered Market Entry Ideas - newser.com

03:21 AM

Oct 13, 2025

Volume spikes in ADMA Biologics Inc. stock – what they mean2025 Top Gainers & Fast Gain Stock Tips - newser.com

Oct 13, 2025

Applying Wyckoff theory to ADMA Biologics Inc. stockPortfolio Performance Summary & Short-Term Swing Trade Alerts - newser.com

Oct 13, 2025

Adma Biologics (ADMA) Is Considered a Good Investment by Brokers: Is That True? - Yahoo Finance

Oct 13, 2025